A phase 2 study shows that azelastine nasal spray lowered coronavirus infection rates to 2.2% compared to 6.7%, researchers ...
The flu causes millions of illnesses, hundreds of thousands of hospitalizations and tens of thousands of deaths each year in ...
Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...
The days of free at-home COVID-19 tests may be over, but the virus certainly hasn’t gone away. With symptoms that overlap ...
A common nasal spray may lower the risk of getting Covid-19, a new study shows. Dr. Leana Wen discusses what this all means as coronavirus cases rise.
A new study has discovered another way to potentially prevent COVID-19. Researchers at Saarland University in Germany headed a clinical trial that found a nasal spray could reduce the risk of ...
Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of innovative in vitro diagnostic technologies, is ...
The symptoms of XFG closely resemble those of other COVID variants, Weber said, and may include: Yes. Studies have shown rapid antigen tests can detect a variety of COVID variants, including XFG, ...
A new study published in the journal of Clinical Infectious Diseases showed that daily use of interferon-alpha (IFN-alpha) ...
Positive tests have increased from 7.6% to 8.4% in a week. Whilst hospitalisations have also increased from 2.00 per 100,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback